Wang Yan

ORCID: 0000-0003-4976-7088
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Sulfur Compounds in Biology
  • Biochemical effects in animals
  • Folate and B Vitamins Research
  • Medical Research and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cardiac Arrest and Resuscitation
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Medical and Biological Ozone Research
  • Artificial Intelligence in Healthcare
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Pediatric Hepatobiliary Diseases and Treatments
  • Spaceflight effects on biology
  • Electrolyte and hormonal disorders
  • Neurological Complications and Syndromes
  • Advanced Glycation End Products research
  • Health and Wellbeing Research
  • Electroconvulsive Therapy Studies
  • Neurological and metabolic disorders
  • Education and Learning Interventions
  • Metabolism and Genetic Disorders
  • Bone health and osteoporosis research
  • Obstructive Sleep Apnea Research
  • Balance, Gait, and Falls Prevention

Kunming Medical University
2024

Xian Yang Central Hospital
2018-2020

The First People’s Hospital of Lianyungang
2020

Third Xiangya Hospital
2018

Central South University
2018

Union Hospital
2013

The dominant artery blood supply is a characteristic of hepatocellular carcinoma (HCC). However, it not known whether the can predict post-hepatectomy prognosis patients with HCC. This retrospective study investigated prognostic value portal venous and arterial estimated on triphasic liver CT (as coefficient, PVC, hepatic HAC, respectively) in HCC following hepatectomy.

10.2147/jhc.s462168 article EN cc-by-nc Journal of Hepatocellular Carcinoma 2024-07-01

This study aimed to investigate whether the routine administration of escitalopram for three months would improve prognosis patients with ischemic stroke and decrease plasma copeptin level. A total 97 acute cerebral infarction were randomly allocated receive (5-10 mg once per day, orally; n=49) or not (control group; n=48) 12 weeks starting at 2-7 days after onset stroke. Both groups received conventional treatments, including physiotherapy secondary prevention The National Institutes Health...

10.1590/1414-431x20208930 article EN cc-by Brazilian Journal of Medical and Biological Research 2020-01-01

10.3980/j.issn.1672-5123.2018.12.05 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2018-12-01
Coming Soon ...